Quantcast

Latest Heart failure Stories

2014-03-30 12:20:07

MADIT-CRT Long-Term Follow-up Results Presented at the American College of Cardiology and Published in the New England Journal of Medicine NATICK, Mass., March 30, 2014 /PRNewswire/ -- In the longest follow-up to date of cardiac resynchronization therapy (CRT) for mild heart failure patients, Boston Scientific Corporation's (NYSE: BSX) exclusively sponsored and landmark Multicenter Automatic Defibrillator Implantation Trial - Cardiac Resynchronization Therapy (MADIT-CRT) study...

2014-03-25 16:26:29

Thought Leaders Present Cases with Etiologies That Lead to End-Stage Biventricular Heart Failure, Including Cardiac Tumor, Transplant Rejection, Ventricular Septal Defect and Chagas Disease TUCSON, Ariz., March 25, 2014 /PRNewswire/ -- Thought leaders in the U.S. heart transplant and mechanical device field recently detailed the best practices for a growing list of uses for the SynCardia temporary Total Artificial Heart, demonstrating how the world's first and only FDA, Health Canada and CE...

2014-03-18 08:31:41

SynCardia Systems, Inc. Continues to Make Progress for Approval of the SynCardia Heart for Permanent Use to Save Patients Who Are Unlikely to Receive Another Donor Heart TUCSON, Ariz., March 18, 2014 /PRNewswire/ -- SynCardia Systems, Inc. is moving forward to gain FDA approval to use the SynCardia temporary Total Artificial Heart as destination therapy (a permanent replacement heart), which could save patients whose donor heart transplant is failing and are unlikely to receive another...

2014-03-14 23:01:56

The Pulmonary Hypertension Association St. Louis Support Group will be hosting a trivia night on March 28 to raise money for research and to create awareness about a life-threatening lung disease, pulmonary hypertension. St. Louis, MO (PRWEB) March 14, 2014 The Pulmonary Hypertension Association St. Louis Support Group will be hosting a trivia night on March 28 to raise money for research and to create awareness about pulmonary hypertension. Pulmonary hypertension is a chronic and...

2014-03-14 12:28:07

WINSTON-SALEM, N.C., March 14, 2014 /PRNewswire/ -- Sara Macy knows that she's been fortunate. http://photos.prnewswire.com/prnvar/20140314/MM83140-a It was 12 years ago that she experienced difficulty breathing on a Saturday morning. She went to a doctor and he suggested that she had a bad case of nerves. During the following week, she added a cough to her list of complaints, and the doctor's diagnosis advanced to a virus. But Macy kept feeling worse, and she visited the doctor...

Prescription Medications Often Work Against Each Other
2014-03-14 10:08:02

David Stauth, Oregon State University About three out of four older Americans have multiple chronic health conditions, and more than 20 percent of them are being treated with drugs that work at odds with each other – the medication being used for one condition can actually make the other condition worse. This approach of treating conditions “one at a time” even if the treatments might conflict with one another is common in medicine, experts say, in part because little information...

2014-03-13 12:29:35

LONDON, March 13, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report: MediPoint: Renal Denervation - EU Analysis and Market Forecasts MediPoint: Renal Denervation - EU Analysis and Market Forecasts SummaryNumerous medical device news sources and industry executives have proclaimed renal denervation to be the top medical device breakthrough of the past two years, and for good reason. Hypertension is one of the most prevalent chronic conditions...

2014-03-12 23:02:34

Collaborative Research Study by Icahn School of Medicine at Mount Sinai, Sanford-Burnham Medical Research Institute, and University of California, San Diego, Shows Blocking microRNA miR-25 Halts Progression of Heart Failure, Improves Cardiac Function, and May Increase Survival New York, NY (PRWEB) March 12, 2014 A team of cardiovascular researchers from the Cardiovascular Research Center at Icahn School of Medicine at Mount Sinai, Sanford-Burnham Medical Research Institute, and University...

2014-03-12 08:29:57

THE REMEDE SYSTEM RECOGNIZED AS 2014 BEST INNOVATION AT CRT CONFERENCE MINNEAPOLIS, March 12, 2014 /PRNewswire/ -- Respicardia(®), Inc., a developer of implantable therapies to improve respiratory and cardiovascular health, announced that it has been awarded the Best Innovation of 2014 from Cardiovascular Research Technologies (CRT) and CV Pipeline for the remed?(®) System, the first and only implantable device for the treatment of central sleep apnea....

2014-03-11 16:26:25

Once Results of Studies Are Approved by the FDA, the Smaller 50cc SynCardia Heart and New Permanent Use Indication Will Triple the Number of Heart Failure Patients Who Can Get a 2nd Chance at Life TUCSON, Ariz., March 11, 2014 /PRNewswire/ -- Recent developments surrounding the SynCardia temporary Total Artificial Heart will make the life-saving device available to three times the number of people suffering from end-stage biventricular heart failure. Over 300 SynCardia Hearts have...


Latest Heart failure Reference Libraries

Circulation (journal)
2012-06-04 14:21:01

Circulation is a scientific journal published by Lippincott Williams & Wilkins on behalf of the American Heart Association. In 2008 the journal added six subspecialty publications: Circulation: Arrhythmia and Electrophysiology, Circulation: Heart Failure, Circulation: Cardiovascular Imaging, Circulation: Cardiovascular Interventions, Circulation: Cardiovascular Quality and Outcomes, and Circulation: Cardiovascular Genetics. Circulation publishes articles related to research in and the...

More Articles (1 articles) »
Word of the Day
drawcansir
  • A blustering, bullying fellow; a pot-valiant braggart; a bully.
This word is named for Draw-Can-Sir, a character in George Villiers' 17th century play The Rehearsal.
Related